ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 756

Nucleosome, a Basic Repeating Unit of Chromatin, in Patients with Systemic Sclerosis: Possible Association with Immunological Abnormalities Via Abnormal Activation of T and B Cells

Ayumi Yoshizaki1, Yoshihide Asano2, Takashi Taniguchi1, Ryosuke Saigusa1, Kouki Nakamura1, Takashi Yamashita1, Takehiro Takahashi1, Tetsuo Toyama1, Yohei Ichimura1, Zenshiro Tamaki1, Miki Miyazaki1 and Shinichi Sato1, 1Dermatology, University of Tokyo Graduate School of Medicine, Tokyo, Japan, 2University of Tokyo Graduate School of Medicine, Tokyo, Japan

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Animal models, Autoimmunity, B cells, nucleosomes and systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Pathogenesis, Animal Models and Genetics

Session Type: Abstract Submissions (ACR)

Background/Purpose

Nucleosome is the basic repeating units of chromatin. Each nucleosome is composed of an inner core of histones H3 and H4 and an outer portion of histones H2A and H2B. Protruding tails of the histones can establish contact with other nucleosomes. In addition, these tails can be modified by methyl-, acetyl-, or ubiquitin-groups. DNA surrounds the protein core about 1.5 times on the flat outside and is connected with histones at 14 sites. Nucleosomes are released from cells during apoptosis and necrosis. Although elevated serum nucleosome levels have been described in various autoimmune disorders, only one previous study has shown that systemic sclerosis (SSc) exhibits elevated serum nucleosome levels in less than 15 patients. In addition, correlations of serum nucleosome levels with immunological parameters and organ involvement were not investigated. Although nucleosome contains DNA and histone, which are major autoantigens of various autoimmune diseases, the relationship of nucleosome and disease progression are still unknown. Therefore, we investigated the role of nucleosome in SSc and correlation of serum nucleosome levels with immunological parameters, extent of skin and lung fibrosis, vascular damage, and presence of other organ involvements in SSc.

Methods Serum nucleosome levels were examined in SSc (n=91) and controls (n=20) by enzyme-linked immunosorbent assay. We also examined serum nucleosome levels in bleomycin-induced SSc model mice and phosphate-buffered saline-treated control mice.

Results

Nucleosome levels in limited cutaneous SSc and diffuse cutaneous SSc patients were significantly higher than in normal controls (p<0.0001, respectively). Similarly, in bleomycin-induced SSc model mice, serum nucleosome levels were higher than in control mice (p<0.0001). SSc patients with elevated nucleosome levels had significantly higher modified Rodnan total skin thickness score, high frequency of diffuse cutaneous SSc, and more frequent involvement of pitting scar/ulcer, pulmonary fibrosis, esophagus, heart, kidneys, joints, and muscle than those with normal levels (p<0.05, respectively). Nucleosome levels also significantly correlated inversely with %VC (r=-0.22, p<0.01) and %DLco (r=-0.68, p<0.001) and positively with modified Rodnan total skin thickness score (r=0.58, p<0.001). SSc patients with elevated nucleosome levels had significantly higher frequency of elevated levels of serum IgG and more frequent presence of anti-topoisomerase I and centromere antibodies compared with those with normal levels (p<0.05, respectively). Moreover, in this study, we demonstrated that nucleosome could activate T and B cells which were obtained from SSc patients.

Conclusion These results suggest that elevation of nucleosome levels is associated with the disease severity. In addition, this study is the first to reveal the association of nucleosome levels with various immunological abnormalities in SSc.


Disclosure:

A. Yoshizaki,
None;

Y. Asano,
None;

T. Taniguchi,
None;

R. Saigusa,
None;

K. Nakamura,
None;

T. Yamashita,
None;

T. Takahashi,
None;

T. Toyama,
None;

Y. Ichimura,
None;

Z. Tamaki,
None;

M. Miyazaki,
None;

S. Sato,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/nucleosome-a-basic-repeating-unit-of-chromatin-in-patients-with-systemic-sclerosis-possible-association-with-immunological-abnormalities-via-abnormal-activation-of-t-and-b-cells/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology